E84.19 Cystic fibrosis with other intestinal manifestations

Name of the Condition

• Cystic Fibrosis with Other Intestinal Manifestations (ICD-10 Code: E84.19)

Summary

Cystic fibrosis with other intestinal manifestations is a subtype of cystic fibrosis involving gastrointestinal complications beyond those classified under more specific codes. It results from abnormal mucus production due to CFTR gene mutations, leading to intestinal obstruction, malabsorption, or other digestive issues. Management focuses on addressing nutritional deficiencies and preventing intestinal complications.

Causes

Cystic fibrosis with other intestinal manifestations is caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which disrupts salt and water transport in cells. These mutations result in defective CFTR protein function, leading to thick, sticky mucus that obstructs intestinal structures. The disorder follows an autosomal recessive inheritance pattern, requiring two mutated gene copies for development.

Risk Factors

• Family history of cystic fibrosis.
• Being of Northern European descent (higher prevalence).
• Carrying one copy of the CFTR mutation (carrier status).

Symptoms

• Intestinal obstruction or blockage.
• Malabsorption leading to poor weight gain or growth.
• Greasy, bulky stools or difficulty with bowel movements.
• Abdominal pain or distension.
• Recurrent intestinal infections or inflammation.

Diagnosis

Diagnosis involves clinical evaluation of gastrointestinal symptoms, genetic testing for CFTR mutations, and imaging studies (e.g., X-rays, CT scans) to assess intestinal structure. Sweat chloride testing may confirm cystic fibrosis, while stool analysis or endoscopy can identify specific intestinal manifestations. Documentation must specify the nature of the intestinal involvement to support the code.

Treatment Options

Treatment includes pancreatic enzyme replacement to improve nutrient absorption, dietary modifications to address malnutrition, and medications to manage intestinal obstruction or inflammation. In severe cases, surgery may be required to relieve blockages. Respiratory therapies and infection prevention are also critical, as cystic fibrosis affects multiple systems.

Prognosis and Follow-Up

Prognosis depends on the severity of intestinal and respiratory involvement. Regular follow-up with a multidisciplinary team (e.g., pulmonologists, gastroenterologists, dietitians) is essential to monitor growth, nutritional status, and lung function. Early intervention can improve outcomes, but lifelong management is required.

Complications

• Intestinal strictures or blockages.
• Malnutrition or vitamin deficiencies.
• Recurrent infections (e.g., pancreatitis, bowel infections).
• Respiratory decline due to overlapping cystic fibrosis effects.

Lifestyle & Prevention

• Adhere to prescribed enzyme and medication regimens.
• Maintain a high-calorie, nutrient-dense diet to support growth.
• Practice good hand hygiene to reduce infection risk.
• Avoid exposure to smoke or respiratory irritants.

When to Seek Professional Help

Seek care if experiencing severe abdominal pain, persistent vomiting, inability to pass stool, or signs of dehydration. Prompt evaluation is critical for intestinal obstruction or infection. Routine follow-up is necessary to monitor disease progression.

Tips for Medical Coders

Document the specific intestinal manifestation (e.g., obstruction, malabsorption) to justify E84.19. Ensure clinical notes link symptoms to cystic fibrosis and exclude more specific codes (e.g., meconium ileus). Verify that CFTR mutation testing or sweat chloride results support the diagnosis when available.